Literature DB >> 21343269

Empiric therapies for Helicobacter pylori infections.

David Y Graham1, Lori A Fischbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21343269      PMCID： PMC3114910          DOI： 10.1503/cmaj.101460

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

Review 1.  Helicobacter pylori treatment in the era of increasing antibiotic resistance.

Authors:  David Y Graham; Lori Fischbach
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

Review 2.  Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group.

Authors:  R H Hunt; F M Smaill; C A Fallone; P M Sherman; S J Veldhuyzen van Zanten; A B Thomson
Journal:  Can J Gastroenterol       Date:  2000-11       Impact factor: 3.522

3.  Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.

Authors:  L A Fischbach; S van Zanten; J Dickason
Journal:  Aliment Pharmacol Ther       Date:  2004-11-15       Impact factor: 8.171

4.  Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.

Authors:  Marco Romano; Antonio Cuomo; Antonietta G Gravina; Agnese Miranda; Maria Rosaria Iovene; Angelo Tiso; Mariano Sica; Alba Rocco; Raffaele Salerno; Riccardo Marmo; Alessandro Federico; Gerardo Nardone
Journal:  Gut       Date:  2010-11       Impact factor: 23.059

5.  Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.

Authors:  Abdallah Said Essa; Jennifer Rosenthal Kramer; David Y Graham; Gerhard Treiber
Journal:  Helicobacter       Date:  2009-04       Impact factor: 5.753

Review 6.  Sequential therapy for Helicobacter pylori eradication: a critical review.

Authors:  Javier P Gisbert; Xavier Calvet; Anthony O'Connor; Francis Mégraud; Colm A O'Morain
Journal:  J Clin Gastroenterol       Date:  2010 May-Jun       Impact factor: 3.062

Review 7.  Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection.

Authors:  Richard Hunt; Carlo Fallone; Sander Veldhuyzan van Zanten; Phil Sherman; Fiona Smaill; Nigel Flook; Alan Thomson
Journal:  Can J Gastroenterol       Date:  2004-09       Impact factor: 3.522

Review 8.  Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.

Authors:  Luigi Gatta; Nimish Vakil; Gioacchino Leandro; Francesco Di Mario; Dino Vaira
Journal:  Am J Gastroenterol       Date:  2009-10-20       Impact factor: 10.864

9.  A report card to grade Helicobacter pylori therapy.

Authors:  David Y Graham; Hong Lu; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2007-08       Impact factor: 5.753

10.  Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.

Authors:  L Fischbach; E L Evans
Journal:  Aliment Pharmacol Ther       Date:  2007-08-01       Impact factor: 8.171
View more
  6 in total

1.  Is quadruple therapy the new triple therapy for H pylori?

Authors:  Christina Korownyk; Michael R Kolber
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

2.  Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors:  Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-17       Impact factor: 11.382

Review 3.  Eradication of Helicobacter pylori infection: which regimen first?

Authors:  Alessandro Federico; Antonietta Gerarda Gravina; Agnese Miranda; Carmela Loguercio; Marco Romano
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

4.  Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.

Authors:  David Y Graham; Yi-Chia Lee; Ming-Shiang Wu
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-08       Impact factor: 11.382

5.  Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?

Authors:  Nuno Almeida; Maria Manuel Donato; José Manuel Romãozinho; Cristina Luxo; Olga Cardoso; Maria Augusta Cipriano; Carol Marinho; Alexandra Fernandes; Carlos Calhau; Carlos Sofia
Journal:  BMC Gastroenterol       Date:  2015-02-15       Impact factor: 3.067

6.  Persister cells as a possible cause of antibiotic therapy failure in Helicobacter pylori.

Authors:  Parvin Bahmaninejad; Sobhan Ghafourian; Mina Mahmoudi; Abbas Maleki; Nourkhoda Sadeghifard; Behzad Badakhsh
Journal:  JGH Open       Date:  2021-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.